Orthofix Medical Inc
$ 12.57
-2.33%
05 Mar - close price
- Market Cap 516,658,000 USD
- Current Price $ 12.57
- High / Low $ 12.73 / 12.45
- Stock P/E N/A
- Book Value 11.30
- EPS -2.33
- Next Earning Report 2026-05-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.05 %
- ROE -0.19 %
- 52 Week High 17.28
- 52 Week Low 10.24
About
Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is headquartered in Lewisville, Texas.
Analyst Target Price
$18.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-03-03 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-03-05 | 2023-11-08 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0.2378 | -0.57 | -0.36 | -1.3549 | 0.0154 | 0.07 | 0.05 | 0.11 | 0.02 | 0.07 | 0.02 | -0.1 |
| Estimated EPS | -0.22 | -0.33 | -0.41 | -0.2667 | -0.05 | -0.15 | -0.19 | -0.33 | -0.08 | -0.21 | -0.47 | -0.51 |
| Surprise | 0.4578 | -0.24 | 0.05 | -1.0882 | 0.0654 | 0.22 | 0.24 | 0.44 | 0.1 | 0.28 | 0.49 | 0.41 |
| Surprise Percentage | 208.0909% | -72.7273% | 12.1951% | -408.024% | 130.8% | 146.6667% | 126.3158% | 133.3333% | 125% | 133.3333% | 104.2553% | 80.3922% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-12 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.65 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OFIX
2026-03-05 04:51:26
Orthofix has commercially launched the Fitbone™ Trochanteric Lengthening System in the United States, expanding its internal limb lengthening portfolio. This new system offers a trochanteric entry option, making it suitable for both adult and pediatric patients, including those with smaller anatomies. It maintains the core electromagnetic technology of Fitbone, providing a bone-conserving, minimally invasive approach for various limb reconstruction needs.
2026-03-02 15:52:32
Canaccord has reduced its price target for Orthofix Medical Inc. (OFIX) from $24 to $20, while maintaining a Buy rating, following the company's Q4 results and updated 2026 outlook. Orthofix projects adjusted EBITDA between $95 million and $98 million and positive free cash flow for 2026. The company plans to focus on commercial execution, market penetration, and the launch of new products to drive consistent revenue growth and improve margins.
2026-02-28 06:52:42
Orthofix Medical Inc. (NASDAQ:OFIX) has received an average "Hold" recommendation from six brokerages, with an average 12-month price target of $18.25. This comes after the medical device company missed Q4 earnings estimates, reporting a loss of ($0.06) versus an expected $0.44, and issued revised 2026 guidance indicating execution risk and margin delays. Despite some insider selling by the CEO and CFO, a major shareholder, Engine Capital, recently increased its stake, and institutional ownership remains high at nearly 90%.
2026-02-27 15:52:18
Orthofix Medical (NASDAQ:OFIX) shares gapped up after major shareholder Engine Capital Management significantly increased its stake by purchasing 124,797 shares at $12.55 and 13,061 shares at $12.96, raising its total holdings to approximately 3.67 million shares. This insider buying activity signals confidence despite Orthofix missing quarterly EPS expectations and management issuing revised 2026 guidance due to margin delays, which led to analyst price target cuts. The company's stock previously closed at $13.17 but opened at $13.79 on Friday following these transactions.
2026-02-27 11:27:00
Orthofix Medical Inc. (OFIX) is a healthcare company specializing in medical devices, particularly in spine and limb reconstruction. Analysts anticipate a 38.57% upside potential from its current trading price of $13.17, with an average target price of $18.25. Despite operational challenges like a negative EPS and ROE, the company shows modest revenue growth and positive analyst sentiment, making it a stock to watch for growth-focused investors.
2026-02-27 02:52:32
Engine Capital, through its associated entities Engine Capital, L.P. and Engine Lift Capital, LP, has increased its stake in Orthofix Medical Inc. (OFIX) by purchasing 137,858 shares in open-market transactions on February 24-25, 2026. The shares were acquired at prices ranging from $12.5455 to $12.9634 per share, making their total holdings indirectly owned. The SEC Form 4 filing also clarifies that the involved Engine Capital units and Arnaud Ajdler may be considered a Section 13(d) group beneficially owning over 10% of Orthofix common stock, though they disclaim beneficial ownership beyond their pecuniary interests.
